Comparison of the effects of gemfibrozil (600 mg twice daily and 900 mg once daily) on lipid and glucose levels in chinese patients with non-insulin-dependent diabetes mellitus

Authors: Ko G.T.C.¹; Yeung V.T.F.; Tsang L.W.W.; Chow C.-C.; Cockram C.S.

Source: Current Therapeutic Research, Volume 56, Number 10, October 1995 , pp. 1033-1040(8)

Publisher: Elsevier

Language: English

Document Type: Research article

DOI: 10.1016/0011-393X(95)85109-7

Affiliations: 1: Diabetes and Endocrine Center, Department of Medicine, Chinese University of Hong Kong, Prince of Wales Hospital, , Shatin, Hong Kong

Links for this article

http://www.ingentaconnect.com/els/0011393x/1995/00000056/00000010/art85109
http://openurl.ingenta.com/content?genre=article&issn=0011-393X&volume=56&issue=10&spage=1033&epage=1040
http://dx.doi.org/10.1016/0011-393X(95)85109-7